Lorlatinib is a third-gen inhibitor that’s made for treating lung cancer that’s spread to other parts and is resistant to other ALK inhibitors. It’s designed to hit these ALK and ROS1 kinases, which helps stop cancer cells from growing. You’ve got two doses available: 25 milligrams and 100 milligrams, both in these coated pill form.
The usual dose is 100 milligrams, taken just once a day, and it doesn’t matter if you take it with or without food. Each bottle holds 30 pills of the stuff. Lorlatinib’s a big deal as a treatment after other ALK inhibitors have failed.
It’s good at stopping cancer growth because it goes after those specific kinases.
Reviews
There are no reviews yet.